TAIWAN · TWSE / TPEx
MVC
高端疫苗 · 6547 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$50.801 month -14.9% · 1 year +32.1%
Directors and supervisors hold56,352,82617.1% of shares issued
Of which pledged24.7%13,933,000
Major shareholders (10%+) hold55,750,84416.9% of shares issued
Revenue, 2026-09+98.8%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 基亞生物科技股份有限公司 | Chairman · Director · Major shareholder (10%+) | 61,743,844 | 55,750,844 | 16.95% | 13,900,000 | — |
| 張銘政 | Chairman (corporate representative) | — | 0 | — | — | — |
| 陳錦燕 | Director (corporate representative) | — | 0 | — | — | — |
| 陳燦堅 | Director | 518,982 | 568,982 | 0.17% | — | — |
| 林家修 | Director | — | 0 | — | — | — |
| 蘇鵬飛 | Independent director | 33,000 | 33,000 | 0.01% | 33,000 | 197,993 |
| 黎耀基 | Independent director | — | 0 | — | — | — |
| 吳明儀 | Independent director | — | 0 | — | — | — |
| 李思賢 | President | — | 100,834 | 0.03% | — | — |
| 柯昇穎 | Vice president | — | 20,000 | 0.01% | — | — |
| 連偉成 | Assistant vice president | — | 104,766 | 0.03% | — | 87,114 |
| 楊郁萍 | Chief financial officer · Chief accountant | — | 491,499 | 0.15% | — | — |
| 陳正揚 | Other | — | 14,794 | 0.00% | — | — |
| 巫清安 | Other | — | 64,488 | 0.02% | — | 1 |
| 謝和儒 | Other | — | 0 | — | — | 255 |
| 高韻涵 | Other | — | 0 | — | — | — |